Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 4Glioma 3Wilms Tumor 2Prostatic Neoplasms 2Glioblastoma 2Carcinoma, Intraductal, Noninfiltrating 2Brain Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Solitary Fibrous Tumor, Pleural 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pancreatic Intraductal Neoplasms 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neuroblastoma 1Neoplasms 1Metastatic Malignant Female Reproductive System Neoplasm 1Mesothelioma, Malignant 1Lung Neoplasms 1Head and Neck Neoplasms 1Germinoma 1Ganglioneuroblastoma 1Extensive Stage Small Cell Lung Carcinoma 1Ependymoma 1Down Syndrome 1Diabetes Insipidus 1Central Nervous System Nongerminomatous Germ Cell Tumor 1Central Nervous System Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 8Specimen Handling 7Biopsy 6X-Rays 5Phantoms, Imaging 5Temozolomide 4Nuclear Medicine Department, Hospital 4Nivolumab 4Carboplatin 4selpercatinib 3larotrectinib 3Topotecan 3Etoposide 3Cyclophosphamide 3Cisplatin 3Automobiles 3tazemetostat 2pembrolizumab 2erdafitinib 2entrectinib 2ensartinib 2cabozantinib 2Vincristine 2Surveys and Questionnaires 2Radiotherapy 2Radiosurgery 2Radiation 2Positron-Emission Tomography 2Paclitaxel 2ONC206 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Radiotherapy, Conformal × 1 year × Clear all
NCT00978458 2025-09-08

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
540 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡